Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Non-Small-Cell Lung 2Tongue Neoplasms 1Recurrent Head and Neck Carcinoma 1Pleural Effusion, Malignant 1Pleural Diseases 1Neoplasm Metastasis 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 2Cetuximab 2talactoferrin alfa 1adavosertib 1Trioxsalen 1Sunitinib 1Radiotherapy, Conformal 1Platinum 1Phototherapy 1Photochemotherapy 1Induction Chemotherapy 1Everolimus 1Docetaxel 1Dihematoporphyrin Ether 1Cyclophosphamide 1Cryosurgery 11-phenyl-3,3-dimethyltriazene 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Tongue Neoplasms × Dihematoporphyrin Ether × Clear all
NCT02068157 2017-10-11

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

Roswell Park Cancer Institute

Phase 2 Terminated
3 enrolled 8 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡